Nymox Pharmaceutical
NYMX
#7609
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-47.37%
Change (1 year)
Categories
Revenue for Nymox Pharmaceutical (NYMX)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Nymox Pharmaceutical from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | N/A | |
| 2022 | N/A | |
| 2021 | N/A | -100% |
| 2020 | $0 M | -95.65% |
| 2019 | $0.11 M | -61.54% |
| 2018 | $0.29 M | 33.48% |
| 2017 | $0.22 M | -21.02% |
| 2016 | $0.28 M | -89.73% |
| 2015 | $2.76 M | -6.38% |
| 2014 | $2.94 M | -12.19% |
| 2013 | $3.35 M | 9.32% |
| 2012 | $3.07 M | -1.32% |
| 2011 | $3.11 M | 349.56% |
| 2010 | $0.69 M | 66.51% |
| 2009 | $0.41 M | -2.89% |
| 2008 | $0.42 M | -1.19% |
| 2007 | $0.43 M | -1.53% |
| 2006 | $0.44 M | 3.18% |
| 2005 | $0.42 M | 32.44% |
| 2004 | $0.32 M | 60.68% |
| 2003 | $0.2 M | -43.95% |
| 2002 | $0.35 M | 52.17% |
| 2001 | $0.23 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.76 B | N/A | 🇺🇸 USA |
 Pfizer PFE | $77.94 B | N/A | 🇺🇸 USA |
 Abbott Laboratories ABT | $40.22 B | N/A | 🇺🇸 USA |
 Eli Lilly LLY | $29.51 B | N/A | 🇺🇸 USA |
 Quest Diagnostics
DGX | $9.48 B | N/A | 🇺🇸 USA |